SCHEMBL2512685

SCHEMBL2512685

CCCN1Cc2cc(OCc3cnccc3OC)ccc2C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 4/20 0.40
PRMT5 O14744 2/20 0.40
WDR77 Q9BQA1 2/20 0.40
GRM1 Q13255 2/20 0.38
GRM5 P41594 1/20 0.38
ITGB3 P05106 2/20 0.38
ITGA2B P08514 1/20 0.38
MAPT P10636 1/20 0.38
S1PR1 P21453 1/20 0.38
TNF P01375 1/20 0.38
AXL P30530 1/20 0.38
EGFR P00533 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2512573 0.94 ADAM17 (0.39) ADAM17PRMT5WDR77GRM5ITGB3
SCHEMBL2509656 0.89 PRMT5 (0.41) ADAM17PRMT5WDR77GRM1GRM5
SCHEMBL2510033 0.84 EGFR (0.43) ADAM17PRMT5WDR77GRM1GRM5
SCHEMBL2511076 0.79 PRMT5 (0.37) ADAM17PRMT5WDR77GRM1GRM5
SCHEMBL2509809 0.76 PRMT5 (0.40) ADAM17PRMT5WDR77ITGB3ITGA2B
SCHEMBL3638895 0.73 ADAM17 (0.42) ADAM17PRMT5WDR77GRM1GRM5
SCHEMBL15164719 0.72 PKN2 (0.42) GRM1GRM5ALDH1A1TSHR
SCHEMBL3632696 0.71 ADAM17 (0.44) ADAM17PRMT5WDR77GRM1GRM5
SCHEMBL3636636 0.71 GRM1 (0.40) ADAM17GRM1GRM5ITGB3ITGA2B
SCHEMBL2512868 0.71 PRMT5 (0.42) ADAM17PRMT5WDR77ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664214-B2 Small molecule potentiators of metabotropic glutamate receptors I AbbVie Deutschland GmbH & Co. KG (DE) 2014-03-04 US claimed
US-8664214-B2 Small molecule potentiators of metabotropic glutamate receptors I AbbVie Deutschland GmbH & Co. KG (DE) 2014-03-04 US disclosed
US-20110245232-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS I ABBOTT GMBH & CO. KG (DE) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245232-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS I GRM3, GRIN2C, GRIN2B ADAM17 4739/4885PRMT5 1226/4885WDR77 2121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.